Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low

Journal of Medical Virology

Volumn 85, Issue 10, 2013, Pages 1712-1723

  Zhao, Rong ^a   Peng, Jinsong ^b   Tang, Li ^b   Huang, Hanju ^a   Liu, Manqing ^b   Kong, Wenhua ^b   Pang, Beibei ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Centers for Disease Prevention and Control   (China)

Author keywords

Co infection; HCV genotype; Hepatitis C virus; HIV; Wuhan

Indexed keywords

ANTIRETROVIRUS AGENT; CORE PROTEIN; NONSTRUCTURAL PROTEIN 5B;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD TRANSFUSION; CD4 LYMPHOCYTE COUNT; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS LOAD; VIRUS TRANSMISSION;

CO-INFECTION; HCV GENOTYPE; HEPATITIS C VIRUS; HIV; WUHAN;

ADULT; AGED; CHINA; CLUSTER ANALYSIS; COINFECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84881025877     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23650     Document Type: Article

References (46)

1. Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, Liu X, Zhou ZQ. 2002. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int 1:194-201.
2. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L. 2008. Changing HCV genotypes distribution in Poland-Relation to source and time of infection. J Clin Virol 42:156-159.
3. Dimitrakopoulos A, Takou A, Haida A, Molangeli S, Gialeraki A, Kordossis T. 2000. The prevalence of hepatitis B and C in HIV-positive Greek patients: Relationship to survival of deceased AIDS patients. J Infect 40:127-131.
4. Dong RL, Wang N, Qiao XC, Ding GW, Jia WQ, Shi XM. 2007. Investigation on HIV-1 co-infection with HCV and HBV in commercial blood donators. Chin J Epidemiol (China) 12:1420-1422.
5. Enomoto N, Takada A, Nakano T, Date T. 1990. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 170:1021-1025.
6. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975-982.
7. Jia M, Luo H, Ma Y, Wang N, Smith K, Mei J, Lu R, Lu J, Fu L, Zhang Q, Wu Z, Lu L. 2010. The HIV epidemic in Yunnan Province, China, 1989-2007. J Acquir Immune Defic Syndr 53:S34-S40.
8. Jiang LJ, Yin H. 2007. The report of co-infection of anti-HIV-positive and the other positive signs. Endem Dis Bull (China) 4:115.
9. Kaur T, Singh J, Tong S, Humphrey C, Clevenger D, Tan W, Szekely B, Wang Y, Li Y, Alex Muse E, Kiyono M, Hanamura S, Inoue E, Nakamura M, Huffman MA, Jiang B, Nishida T. 2008. Descriptive epidemiology of fatal respiratory outbreaks and detection of a human-related metapneumovirus in wild chimpanzees (Pan troglodytes) at Mahale Mountains National Park, Western Tanzania. Am J Primatol 70:755-765.
10. Klenerman P, Kim A. 2007. HCV-HIV co-infection: Simple messages from a complex disease. PLoS Med 4:e240.
11. Lü SQ, Li HP, Yu WL. 2007. Investigation and analysis of different HIV infected groups people co-infected with HCV. Cap Med (China) 20:28.
12. Li JJ, Liu W, Tang ZR, Liang FX, Zhou CX, Liang SJ, Lu HY, Li GZ, Wang B, Wang JW. 2010a. The changes and significance of T lymphocytes and subsets before and after receiving highly active anti-retroviral therapy in children infected with HIV or AIDS patients. Zhonghua Yu Fang Yi Xue Za Zhi 44:989-992.
13. Li N, Wang Z, Sun D, Zhu Q, Sun G, Yang W, Wang Q, Nie Y, Wu Z. 2010b. HIV among plasma donors and other high-risk groups in Henan, China. J Acquir Immune Defic Syndr 53:S41-S47.
14. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. 2005. Hepatitis C virus genotype distribution in China: Predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75:538-549.
15. Mehta S, Cox A, Hoover D, Wang X, Mao Q, Ray S, Strathdee S, Vlahov D, Thomas D. 2002. Protection against persisitence of hepatitis C. Lancet 359:1478-1483.
16. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, Yoffe B. 2001. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 33:240-247.
17. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. 1997. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35:201-207.
18. Peng J, Zhou DJ, Pei DE, Zhou Y, Liu MQ, Tang L, Xu J, Wu XW, Huo WZ, Zhou W. 2007. Study on the distribution of hepatitis C virus genotypes in patients visiting one methadone maintenance clinic in Wuhan. Zhong Hua Liu Xing Bing Xue Za Zhi 28:1207-1210.
19. Peng JS, Wang X, Liu MQ, Zhou DJ, Gong J, Xu HM, Chen JP, Zhu HH, Zhou W, Ho WZ. 2008. Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China. Virus Res 135:191-196.
20. Ramos B, Nunez M, Toro C, Sheldon J, Garcia-Samaniego J, Rios P, Soriano V. 2007. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-co-infected patients. J Infect 54:173-179.
21. Seme K, Vrhovac M, Mocilnik T, Maticic M, Lesnicar G, Baklan Z, Volkar JM, Rajter M, Stepec S, Lunar M, Poljak M. 2009. Hepatitis C virus genotypes in 1, 504 patients in Slovenia, 1993-2007. J Med Virol 81:634-639.
22. Shang H, Zhong P, Liu J, Han X, Dai D, Zhang M, Zhao K, Xu R, Yu XF. 2010. High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. PLoS ONE 5:e10631.
23. Sherman KE, Rouster SD, Chung RT, Rajicic N. 2002. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS clinical trials group. Clin Infect Dis 34:831-837.
24. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, McCaughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F. 2011. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 31:61-80.
25. Staples CT, Jr., Rimland D, Dudas D. 1999. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The effect of co-infection on survival. Clin Infect Dis 29:150-154.
26. Statistics WBo. 2011. Communiqué on Major Data of the sixth national census in Wuhan.
27. Sulkowski MS, Benhamou Y. 2007. Therapeutic issues in HIV/HCV-co-infected patients. J Viral Hepat 14:371-386.
28. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS. 2008. Molecular epidemiology of HCV monoinfection and HIV/HCV co-infection in injection drug users in Liuzhou, Southern China. PLoS ONE 3:e3608.
29. Tedaldi EM, Hullsiek KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, Jenny-Avital ER, McGowan JP, Perez G. 2003. Prevalence and characteristics of hepatitis C virus co-infection in a human immunodeficiency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 36:1313-1317.
30. Thimme R, Spangenberg HC, Blum HE. 2005. Hepatitis B or hepatitis C and human immunodeficiency virus infection. J Hepatol 42:S37-S44.
31. Wang L, Wang N, Li D, Jia M, Gao X, Qu S, Qin Q, Wang Y, Smith K. 2009. The 2007 estimates for people at risk for and living with HIV in China: Progress and challenges. J Acquir Immune Defic Syndr 50:414-418.
32. Wang X, Yao ZY, Yang BF, Wu S, Sun M, Tang L, Liu MQ, Zhou W. 2006a. HIV behavior surveillance and survey in drug users in Wuhan. Chin J Dis Control Prev (China) 10:567-570.
33. Wang YC, Xu SH, Li XH, Song AJ, Jia XR, Zhang H. 2006b. A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users. Chin J Epidemiol (China) 9:777-779.
34. Wasley A, Alter MJ. 2000. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liver Dis 20:1-16.
35. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, Wong BH, Poon RW, Cai JJ, Luk WK, Poon LL, Wong SS, Guan Y, Peiris JS, Yuen KY. 2005. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884-895.
36. Xia X, Luo J, Bai J, Yu R. 2008. Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. Public Health 122:990-1003.
37. Yan H, Li L, Bi Y, Xu X, Li S, Maddock JE. 2011. Family and peer influences on sexual behavior among female college students in Wuhan, China. Women Health 50:767-782.
38. Yan YX, Gao YQ, Sun X, Wang W, Huang XJ, Zhang T, Li M, Zang CP, Li ZC, Wu H. 2010. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 139:354-360.
39. Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren Q, Feng Q, He G. 2011. HCV subtype characterization among injection drug users: Implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS ONE 6:e16817.
40. Zhang KL, Ma SJ. 2002. Epidemiology of HIV in China. BMJ 324:803-804.
41. Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, Yin N, Mei S, Li L, Balfe P, He T, Ba L, Zhang F, Lin HH, Yuen MF, Lai CL, HoD D. 2004. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China. J Virol 78:13591-13599.
42. Zhang W, Hu D, Xi Y, Zhang M, Duan G. 2006a. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS. Int J Infect Dis 10:475-480.
43. Zhang WD, Xi YL, Zhang MX, Duan GC. 2006b. Co-infection of HIV, HBV, and HCV in a village with high prevalence rate of blood-related AIDS. J Zhengzhou Univ (Med Sci) (China) 2:254-256.
44. Zhang YY, Lok AS, Chan DT, Widell A. 1995. Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China. J Clin Microbiol 33:2931-2934.
45. Zhou DX, Tang JW, Chu IM, Cheung JL, Tang NL, Tam JS, Chan PK. 2006. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong. J Med Virol 78:574-581.
46. Zhou HY, Zheng YH, He Y, Chen Z, Liu M, Yin W, Liu C. 2011. Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients. Intervirology 53:240-246.